Public Company News

FLJ GROUP LIMITED RECEIVES NASDAQ MINIMUM BID PRICE DEFICIENCY NOTICE

SHANGHAI, April 9, 2024 /PRNewswire/ -- FLJ Group Limited (NASDAQ:FLJ) (the "Company"), today announced that it has received a notice from the Nasdaq Stock Market LLC ("Nasdaq") datedApril 3, 2024 stating that the Company is not in compliance with the requirement to maintain a minimum bid price o...

2024-04-09 21:00 4111

Taoping Reports Record 1Q 2024 Contract Revenue with 53% Increase Compared to 1Q 2023

SHENZHEN, China, April 9, 2024 /PRNewswire/ -- Taoping Inc. (Nasdaq: TAOP, the "Company"), a developer of innovative smart cloud platform services and solutions, new media and artificial intelligence solutions, today reported a total contract revenue value ofRMB 60.1 million (approximately USD $8...

2024-04-09 20:50 4309

Hitek Global Inc. Announces Fiscal Year 2023 Financial Results

XIAMEN, China, April 9, 2024 /PRNewswire/ -- Hitek Global Inc. (Nasdaq: HKIT) (the "Company"), a China-based information technology consulting and solutions service provider, today announced its financial results for the fiscal year endedDecember 31, 2023. Ms. Xiaoyang Huang, Chief Executive Off...

2024-04-09 20:30 4207

LG Innotek CEO Moon Hyuksoo aims to be the top in ADAS sensing by using 'High Performance LiDAR'.

* Overcoming limitations of existing LiDAR with Shortwave Infrared Rays...Detection range tripled * Various line-ups tailored to customers...Secured differentiated capacity by acquiring Argo patents * "Aiming to become No.1 in sensing solution for ADAS based on top-tier DNA in optics" SEOUL...

2024-04-09 20:00 2328

Jacobio Pharma to Present Data of PARP7 Inhibitor and P53 Reactivator at the 2024 AACR Annual Meeting

BEIJING, SHANGHAI, and SAN DIEGO, April 9, 2024 /PRNewswire/ -- Jacobin Pharma (1167.HK), a clinical-stage oncology company focusing on undruggable targets, today announced that the company will present the results of two preclinical evaluation of PARP7 inhibitor JAB-26766 and p53 Y220C reactivat...

2024-04-09 19:59 2605

Fibocom's 5G Premium Smart Module SC171 Awarded as the Best-in-Show Embedded Computing Design at Embedded World 2024

NUREMBERG, Germany, April 9, 2024 /PRNewswire/ -- Fibocom (Stock code: 300638), a global leading provider of IoT (Internet of Things) wireless solutions and wireless communication modules, is proud of winning the Embedded Computing Design's Best in Show award during Embedded World 2024 with groun...

2024-04-09 17:00 2433

Abbisko Completed All Patient Enrollment for The Global Phase III TGCT Trial of Its CSF-1R Inhibitor - Pimicotinib

SHANGHAI, April 8, 2024 /PRNewswire/ -- 9 April 2024 (Beijing Time), Abbisko Therapeutics Co., Ltd. (Abbisko Therapeutics) announced the completion of patient enrollment for its pivotal Phase III trial, MANEUVER (ABSK021-301) STUDY, for evaluating the efficacy and safety of pimicotinib in patient...

2024-04-09 08:30 2096

Oral report | The positive interim analysis results from the Phase III clinical study of Akeso's Cadonilimab (PD-1/CTLA-4 BsAb) plus chemotherapy as first-line treatment for advanced gastric cancer presented at 2024 AACR

SAN DIEGO, April 8, 2024 /PRNewswire/ -- Akeso, Inc. (9926.HK) today announced thatthe positive interim analysis results from Phase III clinical study of Cadonilimab (PD-1/CTLA-4 BsAb)combined with XELOX (capecitabine plus oxaliplatin) as first-line treatment for unresectable locally advanced or ...

2024-04-09 04:53 2741

Nano Labs Files Annual Report on Form 20-F for Fiscal Year 2023

HANGZHOU, China, April 8, 2024 /PRNewswire/ -- Nano Labs Ltd (Nasdaq: NA) ("we," the "Company" or "Nano Labs"), a leading fabless integrated circuit design company and product solution provider inChina, announced today that it filed its annual report on Form 20-F for the fiscal year endedDecember...

2024-04-09 04:45 4137

Ace Global Business Acquisition Limited Announces Extension of Combination Period and Additional Contribution to Trust Account to Extend Combination Period

NEW YORK, April 8, 2024 /PRNewswire/ -- Ace Global Business Acquisition Limited (NASDAQ: ACBA) (the "Company"), a special purpose acquisition company, announced today that at its annual general meeting of shareholders onApril 2, 2024, the Company's shareholders voted in favor of the proposal to a...

2024-04-08 22:00 4180

MAIWEIJIAN, First Approved Biosimilar of Denosumab (120mg) in China

SHANGHAI, April 8, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that Denosumab Injection (trade name: MAIWEIJIAN, R&D code: 9MW0321) developed by its wholly-owned subsidiary T-mab has officially obtained the market...

2024-04-08 22:00 2047

Medit Unveils i900: The Next Evolution of Intraoral Scanners

Secure a front-row seat for the debut of Medit i900 and discover the latest cutting-edge dental technology SEOUL, South Korea and LONG BEACH, Calif., April 8, 2024 /PRNewswire/ -- Medit (www.medit.com ), a leading provider of dental 3D scanners and digital dentistry solut...

2024-04-08 21:00 2478

Lunit's AI Demonstrates Up to 70% Workload Reduction and Enhanced Accuracy in Breast Cancer Screening: Study in European Radiology Reveals

- Employing Lunit INSIGHT MMG, a Turkish study showcases 70% efficiency improvements, advancements in early cancer detection, and interval cancer detection in mammography SEOUL, South Korea, April 8, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cance...

2024-04-08 21:00 2638

Aquaron Acquisition Corp. Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination

NEW YORK, April 8, 2024 /PRNewswire/ -- Aquaron Acquisition Corp. (NASDAQ: AQU, the "Company"), a special purpose acquisition company, announced today that Bestpath IoT Technology Ltd. ("Bestpath") has deposited into the Company's trust account (the "Trust Account") an aggregate of $70,000, in or...

2024-04-08 18:30 3901

U Power To Launch Commercial Operation for its EV Battery Swapping System

SHANGHAI, April 8, 2024 /PRNewswire/ -- U Power Limited (Nasdaq: UCAR) (the "Company" or "U Power"), a vehicle sourcing services provider with a vision to becoming a comprehensive EV battery power solution provider inChina, today announced that its battery-swapping and sharing model for two-wheel...

2024-04-08 18:00 4333

Weibo to Hold Annual General Meeting on May 22, 2024

BEIJING, April 8, 2024 /PRNewswire/ -- Weibo Corporation (the "Weibo" or "Company") (Nasdaq: WB and HKEX: 9898), China's leading social media platform, today published a notice to announce that it will hold an annual general meeting (the "AGM") of shareholders (the "Notice of AGM") at 5809-5810, ...

2024-04-08 17:45 4221

MoonFox Analysis | Xiaomi Cars were Finally Released, and How About the Group's Confidence?

About us: Aurora Mobile (NASDAQ: JG) established in 2011, is a leading customer engagement and marketing technology service provider inChina. Its business includes notification services, marketing growth, development tools, and data products. As its sub-brand, MoonFox Data is a leading expert in ...

2024-04-08 12:00 2366

Macronix Non-Volatile Memory Solutions Showcase with Partners NXP, ST at embedded world 2024

NUREMBERG, Germany, April 7, 2024 /PRNewswire/ -- Macronix International Co., Ltd. (TSE: 2337), a leading integrated-device manufacturer of non-volatile memory (NVM) solutions, will have its versatile NVM solutions showcased at embedded world 2024 through its partnerships with industry leaders NXP...

2024-04-08 09:15 2661

Laekna Announces Two Poster Presentations on Internally Discovered Drug Candidates at AACR 2024

SHANGHAI and WARREN, N.J., April 7, 2024 /PRNewswire/ -- Laekna (2105.HK) announced that the company has presented two internally-discovered preclinical candidates, in addition to a poster presentation on a clinical trial, at the 2024 Annual Meeting of the American Association for Cancer Research...

2024-04-08 08:30 1967

AACR 2024 | Ascentage Pharma Presents Results from Three Studies at 2024 American Association of Cancer Research Annual Meeting

ROCKVILLE, Md. and SUZHOU, China, April 7, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, age-related diseases, and chronic hepatitis B (CHB), announced today that it releases the latest results from three pre...

2024-04-08 07:58 2138
1 ... 278279280281282283284 ... 772